TradingView
UnknownUnicorn1043646
26 de May. de 2021 15:26
Short Squeeze - CMMB
Largo
NASDAQ:CMMB
1S
Chemomab Therapeutics Ltd.
NASDAQ
Descripción
⋅
26 de May. de 2021 15:26
Idea for Chemomab Therapeutics Ltd.:
- 131% borrow fee for shares. 47 shares available for borrow, according to iborrowdesk.
- Bottom of Risk Range:
- S3 Filing Sales Agreement with Cantor Fitzgerald & Co. dated Apr 30, 2021.
fintel.io/doc/sec-chemomab-therapeutics-ltd-ex12-2021-april-30-18747-818
- Cantor Fitzgerald assigned overweight rating on CMMB and raised price target to $45.
marketbeat.com/ratings/by-issuer/cantor-fitzgerald-stock-recommendations/
- Good short squeeze material.
- Non Optionable.
Bought the shares $16.69
Expect share dilution $40-$50
GLHF
- DPT
Orden cancelada
⋅
1 de Jun. de 2021 15:31
Trend Analysis
Fundamental Analysis
Beyond Technical Analysis
CMMB
shortsqueeze
biotech
covidstocks
darkpooltrading
highshort
Comentarios
brandonlee485
⋅
11 de Jun. de 2021 3:41
You closed your trade too early lol.
brandonlee485
⋅
31 de May. de 2021 7:45
Have you been able to find a utilization rate for this stock?
Wilson5s
⋅
27 de May. de 2021 23:12
when do you think this bad boy can squueze?
Más